Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
| NOC | Date | Submission | Reason |
|---|
| 29370 | 2022-11-03 | Supplement to a New Drug Submission (SNDS) | Addition of a drug product manufacturing site, label updates |
| 20194 | 2017-12-22 | New Drug Submission (NDS) | Administrative - Merger/Buyout |
| 18650 | 2016-11-09 | Supplement to a New Drug Submission (SNDS) | LABELLING UPDATE |
| 9138 | 2007-10-26 | Supplement to a New Drug Submission (SNDS) | LABELLING UPDATE: POTENTIAL ANTI-INFLAMMATORY EFFECT (MODE OF ACTION) |
| 5766 | 2004-11-05 | New Drug Submission (NDS) | |
| 6844 | 1998-10-01 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR THE DELETION OF THE WEIGTH RESTRICTION IN CALVES LESS THAN 70 KG BODY WEIGHT |